Clinical Study

A Phase 3, Randomized, Double-Blind, Efficacy And Safety Study Comparing Sar442168 To Placebo In Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis (Hercules)

Posted Date: Oct 27, 2020

  • Investigator: Lawrence Goldstick
  • Specialties: Multiple Sclerosis, Neurology
  • Type of Study: Drug

A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis (HERCULES)




Multiple Sclerosis, Secondary Progressive, Sar442168

For More Information:

Christina Dowdy

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.